Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Sep 15, 2026
Sale
Shares
600
Price
$40.38
Total Value
$24.23K
Shares Held After
9,900
% of Holdings
5.7%
Sep 15, 2026
Sale
Shares
4,712
Price
$39.68
Total Value
$186.97K
Shares Held After
36,508
% of Holdings
11.4%
Sep 15, 2026
Sale
Shares
4,338
Price
$39.65
Total Value
$172.00K
Shares Held After
10,500
% of Holdings
29.2%

Adaptive Biotechnologies Corp (ADPT)

BOBULSKY SUSAN — Chief Commercial Officer, MRD
Sep 15, 2026
Sale
Shares
1,195
Price
$27.00
Total Value
$32.27K
Shares Held After
395,794
% of Holdings
0.3%
Sep 15, 2026
Sale
Shares
3,000
Price
$28.58
Total Value
$85.74K
Shares Held After
6,200
% of Holdings
32.6%

Theravance Biopharma, Inc. (TBPH)

Farnum Rhonda — SVP, COMM&MEDICAL AFFAIRS
Sep 15, 2026
Sale
Shares
6,657
Price
$17.03
Total Value
$113.40K
Shares Held After
213,476
% of Holdings
3.0%

Theravance Biopharma, Inc. (TBPH)

Farnum Rhonda — SVP, COMM&MEDICAL AFFAIRS
Sep 15, 2026
Sale
Shares
3,328
Price
$17.03
Total Value
$56.69K
Shares Held After
220,133
% of Holdings
1.5%

Theravance Biopharma, Inc. (TBPH)

Farnum Rhonda — SVP, COMM&MEDICAL AFFAIRS
Sep 15, 2026
Sale
Shares
3,329
Price
$17.03
Total Value
$56.71K
Shares Held After
223,461
% of Holdings
1.5%
Sep 15, 2026
Sale
Shares
66
Price
$80.01
Total Value
$5.28K
Shares Held After
94,487
% of Holdings
0.1%
Sep 15, 2026
Sale
Shares
759
Price
$79.00
Total Value
$59.96K
Shares Held After
94,553
% of Holdings
0.8%
Sep 15, 2026
Sale
Shares
11,675
Price
$78.33
Total Value
$914.50K
Shares Held After
95,312
% of Holdings
10.9%

Hims&Hers Health, Inc. (HIMS)

Chi Michael — Chief Operating Officer
Sep 15, 2026
Sale
Shares
14,027
Price
$28.39
Total Value
$398.23K
Shares Held After
456,660
% of Holdings
3.0%
Sep 15, 2026
Sale
Shares
100,000
Price
$13.67
Total Value
$1.37M
Shares Held After
467,969
% of Holdings
17.6%
Sep 15, 2026
Sale
Shares
7,954
Price
$28.39
Total Value
$225.81K
Shares Held After
185,556
% of Holdings
4.1%
Sep 15, 2026
Sale
Shares
15,971
Price
$620.84
Total Value
$9.92M
Shares Held After
523,923
% of Holdings
3.0%

INCYTE CORP (INCY)

CAGNONI PABLO J — President, Global Head of R&D
Sep 15, 2026
Sale
Shares
13,985
Price
$120.49
Total Value
$1.69M
Shares Held After
183,200
% of Holdings
7.1%

INCYTE CORP (INCY)

CAGNONI PABLO J — President, Global Head of R&D
Sep 15, 2026
Sale
Shares
9,233
Price
$120.50
Total Value
$1.11M
Shares Held After
197,185
% of Holdings
4.5%
Sep 15, 2026
Sale
Shares
4,730
Price
$24.18
Total Value
$114.37K
Shares Held After
35,841
% of Holdings
11.7%
Sep 15, 2026
Sale
Shares
982
Price
$7.63
Total Value
$7.49K
Shares Held After
576,764
% of Holdings
0.2%

Pharvaris N.V. (PHVS)

Abele Stefan Andreas — Chief Technical Ops Officer
Sep 15, 2026
Sale
Shares
1,400
Price
$39.24
Total Value
$54.94K
Shares Held After
39,068
% of Holdings
3.5%

Pharvaris N.V. (PHVS)

Abele Stefan Andreas — Chief Technical Ops Officer
Sep 15, 2026
Sale
Shares
45,000
Price
$38.14
Total Value
$1.72M
Shares Held After
40,468
% of Holdings
52.7%

Pharvaris N.V. (PHVS)

Glassman Robert — Director
Sep 15, 2026
Sale
Shares
8,667
Price
$38.27
Total Value
$331.72K
Shares Held After
10,500
% of Holdings
45.2%

GILEAD SCIENCES, INC. (GILD)

Mercier Johanna — Chief Comm&Corp Aff Officer
Sep 15, 2026
Sale
Shares
600
Price
$145.29
Total Value
$87.17K
Shares Held After
116,684
% of Holdings
0.5%

GILEAD SCIENCES, INC. (GILD)

Mercier Johanna — Chief Comm&Corp Aff Officer
Sep 15, 2026
Sale
Shares
800
Price
$144.46
Total Value
$115.57K
Shares Held After
117,284
% of Holdings
0.7%

GILEAD SCIENCES, INC. (GILD)

Mercier Johanna — Chief Comm&Corp Aff Officer
Sep 15, 2026
Sale
Shares
1,600
Price
$143.69
Total Value
$229.91K
Shares Held After
118,084
% of Holdings
1.3%

DEXCOM INC (DXCM)

Brown Michael Jon — EVP Chief Legal Compliance Off
Sep 15, 2026
Sale
Shares
1,700
Price
$84.04
Total Value
$142.87K
Shares Held After
99,885
% of Holdings
1.7%

DEXCOM INC (DXCM)

AUGUSTINOS NICHOLAS — Director
Sep 15, 2026
Sale
Shares
6,539
Price
$84.04
Total Value
$549.54K
Shares Held After
29,293
% of Holdings
18.2%

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Wai Conrad — CEO, Counterpart Health
Sep 15, 2026
Sale
Shares
300,000
Price
$4.72
Total Value
$1.42M
Shares Held After
1,170,056
% of Holdings
20.4%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Sep 15, 2026
Sale
Shares
2,000
Price
$350.01
Total Value
$700.01K
Shares Held After
0
% of Holdings
100.0%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Sep 15, 2026
Sale
Shares
800
Price
$351.25
Total Value
$281.00K
Shares Held After
2,125,394
% of Holdings
0.0%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Sep 15, 2026
Sale
Shares
14,500
Price
$350.81
Total Value
$5.09M
Shares Held After
2,126,194
% of Holdings
0.7%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Sep 15, 2026
Sale
Shares
4,206
Price
$349.51
Total Value
$1.47M
Shares Held After
2,140,694
% of Holdings
0.2%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Sep 15, 2026
Sale
Shares
8,094
Price
$348.65
Total Value
$2.82M
Shares Held After
2,144,900
% of Holdings
0.4%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Sep 15, 2026
Sale
Shares
2,700
Price
$347.81
Total Value
$939.09K
Shares Held After
2,152,994
% of Holdings
0.1%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Sep 15, 2026
Sale
Shares
1,122
Price
$346.68
Total Value
$388.97K
Shares Held After
2,155,694
% of Holdings
0.1%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Sep 15, 2026
Sale
Shares
2,700
Price
$345.38
Total Value
$932.53K
Shares Held After
2,156,816
% of Holdings
0.1%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Sep 15, 2026
Sale
Shares
5,839
Price
$344.49
Total Value
$2.01M
Shares Held After
2,159,516
% of Holdings
0.3%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Sep 15, 2026
Sale
Shares
2,240
Price
$343.56
Total Value
$769.58K
Shares Held After
2,165,355
% of Holdings
0.1%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Sep 15, 2026
Sale
Shares
1,956
Price
$342.18
Total Value
$669.30K
Shares Held After
2,167,595
% of Holdings
0.1%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Sep 15, 2026
Sale
Shares
1,813
Price
$341.41
Total Value
$618.97K
Shares Held After
2,169,551
% of Holdings
0.1%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Sep 15, 2026
Sale
Shares
2,549
Price
$340.25
Total Value
$867.29K
Shares Held After
2,171,364
% of Holdings
0.1%

Natera, Inc. (NTRA)

Rabinowitz Matthew — Director
Sep 15, 2026
Sale
Shares
1,481
Price
$339.24
Total Value
$502.41K
Shares Held After
2,173,913
% of Holdings
0.1%

Integer Holdings Corp (ITGR)

Thor Kirk K — Chief Human Resources Officer
Sep 15, 2026
Sale
Shares
11,767
Price
$126.23
Total Value
$1.49M
Shares Held After
7,153
% of Holdings
62.2%
Sep 15, 2026
Purchase
Shares
54,256
Price
$1.30
Total Value
$70.45K
Shares Held After
883,761
% of Holdings
6.1%

TELA Bio, Inc. (TELA)

Capper Joseph H — Director
Sep 15, 2026
Purchase
Shares
50,000
Price
$1.06
Total Value
$52.94K
Shares Held After
104,827
% of Holdings
47.7%
Sep 15, 2026
Purchase
Shares
3,774
Price
$6.00
Total Value
$22.64K
Shares Held After
100,996
% of Holdings
3.7%
Sep 15, 2026
Sale
Shares
30,000
Price
$74.58
Total Value
$2.24M
Shares Held After
0
% of Holdings
100.0%

BioNTech SE (BNTX)

Sahin Ugur — Chief Executive Officer
Sep 15, 2026
Sale
Shares
34,000
Price
$96.49
Total Value
$3.28M
Shares Held After
568,209
% of Holdings
5.6%

Moderna, Inc. (MRNA)

Hoge Stephen — President
Sep 15, 2026
Sale
Shares
40,281
Price
$146.07
Total Value
$5.88M
Shares Held After
1,562,029
% of Holdings
2.5%
Sep 15, 2026
Sale
Shares
650
Price
$504.57
Total Value
$327.97K
Shares Held After
324,443
% of Holdings
0.2%
Version: v26.10.6